# DocGo Inc.: filings

DCGO · Nasdaq · CIK 1822359 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dcgo.md) · [Financials](/companies/dcgo/financials.md) · [Filings](/companies/dcgo/filings.md) · [Insiders](/companies/dcgo/insiders.md)

## Reports and events: 116 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 137, 8-K 66, 424B3 19, 10-Q 18, 144 18, 3 18, 5 12, SC 13G/A 12, CORRESP 11, 425 9, SC 13G 8, UPLOAD 8, 8-K/A 7, 10-K 6, DEF 14A 5, DEFA14A 5, EFFECT 5, S-4/A 5, ARS 4, 10-K/A 3, S-1/A 3, S-8 3, 10-Q/A 2, 144/A 2, 25-NSE 2, 3/A 2, NT 10-Q 2, POS AM 2, PRE 14A 2, S-1 2, SC 13D 2, SCHEDULE 13G/A 2, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, DRS 1, S-4 1, SC 13D/A 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 10:32 ET | [8-K](/filings/0001628280-26-064740.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events | 0001628280-26-064740 |
| 2026-08-17 | 20:35 ET | [10-Q](/filings/0001628280-26-057394.md) | Quarterly report, period 2026-06-30 | 0001628280-26-057394 |
| 2026-08-17 | 20:24 ET | [8-K](/filings/0001628280-26-057387.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-057387 |
| 2026-07-31 | 20:06 ET | [8-K](/filings/0001628280-26-051396.md) | 3.01 Delisting notice | 0001628280-26-051396 |
| 2026-07-02 | 20:17 ET | [8-K](/filings/0001628280-26-046919.md) | 7.01 Regulation FD disclosure | 0001628280-26-046919 |
| 2026-06-18 | 21:06 ET | [8-K](/filings/0001628280-26-044414.md) | 5.07 Shareholder vote results | 0001628280-26-044414 |
| 2026-05-11 | 20:32 ET | [10-Q](/filings/0001628280-26-033563.md) | Quarterly report, period 2026-03-31 | 0001628280-26-033563 |
| 2026-05-11 | 20:09 ET | [8-K](/filings/0001822359-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-26-000020 |
| 2026-04-22 | 20:06 ET | [DEF 14A](/filings/0001213900-26-046600.md) | Proxy statement, period 2026-06-16 | 0001213900-26-046600 |
| 2026-04-22 | 01:32 ET | [8-K](/filings/0001822359-26-000017.md) | 5.02 Departure or appointment of officers or directors | 0001822359-26-000017 |
| 2026-03-16 | 20:30 ET | [10-K](/filings/0001628280-26-018214.md) | Annual report, period 2025-12-31 | 0001628280-26-018214 |
| 2026-03-16 | 20:08 ET | [8-K](/filings/0001822359-26-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-26-000009 |
| 2026-02-26 | 21:13 ET | [SCHEDULE 13D/A](/filings/0001409310-26-000004.md) | Ownership report, active investor, amended | 0001409310-26-000004 |
| 2026-01-30 | 22:12 ET | [8-K](/filings/0001822359-26-000003.md) | 3.01 Delisting notice | 0001822359-26-000003 |
| 2025-12-12 | 21:08 ET | [8-K](/filings/0001822359-25-000080.md) | 7.01 Regulation FD disclosure | 0001822359-25-000080 |
| 2025-11-10 | 21:39 ET | [10-Q](/filings/0001628280-25-051102.md) | Quarterly report, period 2025-09-30 | 0001628280-25-051102 |
| 2025-11-10 | 21:07 ET | [8-K](/filings/0001628280-25-051026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-051026 |
| 2025-10-21 | 01:58 ET | [8-K/A](/filings/0001213900-25-100516.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-100516 |
| 2025-10-20 | 21:01 ET | [8-K](/filings/0001213900-25-100412.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-100412 |
| 2025-08-07 | 20:47 ET | [8-K](/filings/0001822359-25-000077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-25-000077 |
| 2025-08-07 | 20:19 ET | [10-Q](/filings/0001822359-25-000074.md) | Quarterly report, period 2025-06-30 | 0001822359-25-000074 |
| 2025-06-18 | 20:21 ET | [8-K](/filings/0001822359-25-000062.md) | 5.07 Shareholder vote results | 0001822359-25-000062 |
| 2025-06-12 | 20:22 ET | [8-K](/filings/0001822359-25-000060.md) | 7.01 Regulation FD disclosure | 0001822359-25-000060 |
| 2025-05-08 | 20:35 ET | [10-Q](/filings/0001822359-25-000042.md) | Quarterly report, period 2025-03-31 | 0001822359-25-000042 |
| 2025-05-08 | 20:15 ET | [8-K](/filings/0001822359-25-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-25-000040 |
| 2025-04-24 | 20:11 ET | [DEF 14A](/filings/0001213900-25-035063.md) | Proxy statement, period 2025-06-17 | 0001213900-25-035063 |
| 2025-02-27 | 21:33 ET | [10-K](/filings/0001822359-25-000018.md) | Annual report, period 2024-12-31 | 0001822359-25-000018 |
| 2025-02-27 | 21:16 ET | [8-K](/filings/0001822359-25-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-25-000017 |
| 2024-12-20 | 21:05 ET | [8-K](/filings/0001822359-24-000119.md) | 7.01 Regulation FD disclosure | 0001822359-24-000119 |
| 2024-11-29 | 21:14 ET | [SC 13D/A](/filings/0001822359-24-000100.md) | Ownership report, active investor, amended | 0001822359-24-000100 |
| 2024-11-07 | 21:34 ET | [10-Q](/filings/0001822359-24-000094.md) | Quarterly report, period 2024-09-30 | 0001822359-24-000094 |
| 2024-11-07 | 21:16 ET | [8-K](/filings/0001822359-24-000092.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-24-000092 |
| 2024-09-30 | 11:40 ET | [8-K](/filings/0001822359-24-000085.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001822359-24-000085 |
| 2024-08-07 | 20:37 ET | [10-Q](/filings/0001822359-24-000081.md) | Quarterly report, period 2024-06-30 | 0001822359-24-000081 |
| 2024-08-07 | 20:19 ET | [8-K](/filings/0001822359-24-000079.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-24-000079 |
| 2024-06-18 | 20:28 ET | [8-K](/filings/0001822359-24-000058.md) | 5.07 Shareholder vote results | 0001822359-24-000058 |
| 2024-05-08 | 20:36 ET | [10-Q](/filings/0001822359-24-000045.md) | Quarterly report, period 2024-03-31 | 0001822359-24-000045 |
| 2024-05-08 | 20:13 ET | [8-K](/filings/0001822359-24-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-24-000043 |
| 2024-05-07 | 20:46 ET | [8-K](/filings/0001822359-24-000037.md) | 8.01 Other events | 0001822359-24-000037 |
| 2024-04-25 | 20:19 ET | [DEF 14A](/filings/0001213900-24-036220.md) | Proxy statement, period 2024-06-18 | 0001213900-24-036220 |
| 2024-04-10 | 11:26 ET | [8-K](/filings/0001822359-24-000035.md) | 7.01 Regulation FD disclosure | 0001822359-24-000035 |
| 2024-03-08 | 12:06 ET | [8-K](/filings/0001822359-24-000018.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001822359-24-000018 |
| 2024-02-28 | 21:23 ET | [10-K](/filings/0001822359-24-000016.md) | Annual report, period 2023-12-31 | 0001822359-24-000016 |
| 2024-02-28 | 21:09 ET | [8-K](/filings/0001822359-24-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-24-000014 |
| 2024-01-31 | 12:41 ET | [8-K](/filings/0001822359-24-000009.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822359-24-000009 |
| 2024-01-16 | 12:42 ET | [8-K](/filings/0001822359-24-000007.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822359-24-000007 |
| 2024-01-10 | 21:24 ET | [8-K](/filings/0001822359-24-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822359-24-000005 |
| 2023-11-06 | 21:45 ET | [10-Q](/filings/0001822359-23-000032.md) | Quarterly report, period 2023-09-30 | 0001822359-23-000032 |
| 2023-11-06 | 21:15 ET | [8-K](/filings/0001822359-23-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822359-23-000031 |
| 2023-10-24 | 10:44 ET | [8-K](/filings/0001822359-23-000025.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822359-23-000025 |

Page 1 of 3. [Older](/companies/dcgo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.